InspireMD Statistics
Total Valuation
InspireMD has a market cap or net worth of $94.71 million. The enterprise value is $78.76 million.
Important Dates
The next confirmed earnings date is Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
InspireMD has 41.72 million shares outstanding. The number of shares has increased by 43.97% in one year.
| Current Share Class | 41.72M |
| Shares Outstanding | 41.72M |
| Shares Change (YoY) | +43.97% |
| Shares Change (QoQ) | +2.02% |
| Owned by Insiders (%) | 20.07% |
| Owned by Institutions (%) | 26.90% |
| Float | 28.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.95 |
| Forward PS | 8.83 |
| PB Ratio | 3.65 |
| P/TBV Ratio | 4.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.81 |
| Quick Ratio | 2.37 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -123.51% and return on invested capital (ROIC) is -73.70%.
| Return on Equity (ROE) | -123.51% |
| Return on Assets (ROA) | -59.42% |
| Return on Invested Capital (ROIC) | -73.70% |
| Return on Capital Employed (ROCE) | -174.29% |
| Revenue Per Employee | $82,163 |
| Profits Per Employee | -$481,174 |
| Employee Count | 86 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 2.12 |
Taxes
In the past 12 months, InspireMD has paid $59,000 in taxes.
| Income Tax | 59,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.72% in the last 52 weeks. The beta is 0.60, so InspireMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -7.72% |
| 50-Day Moving Average | 2.39 |
| 200-Day Moving Average | 2.55 |
| Relative Strength Index (RSI) | 40.93 |
| Average Volume (20 Days) | 68,557 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, InspireMD had revenue of $7.07 million and -$41.38 million in losses. Loss per share was -$0.83.
| Revenue | 7.07M |
| Gross Profit | 1.49M |
| Operating Income | -42.31M |
| Pretax Income | -41.32M |
| Net Income | -41.38M |
| EBITDA | -41.96M |
| EBIT | -42.31M |
| Loss Per Share | -$0.83 |
Full Income StatementBalance Sheet
The company has $19.37 million in cash and $3.42 million in debt, giving a net cash position of $15.95 million or $0.38 per share.
| Cash & Cash Equivalents | 19.37M |
| Total Debt | 3.42M |
| Net Cash | 15.95M |
| Net Cash Per Share | $0.38 |
| Equity (Book Value) | 20.24M |
| Book Value Per Share | 0.62 |
| Working Capital | 16.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$29.58 million and capital expenditures -$1.67 million, giving a free cash flow of -$31.24 million.
| Operating Cash Flow | -29.58M |
| Capital Expenditures | -1.67M |
| Free Cash Flow | -31.24M |
| FCF Per Share | -$0.75 |
Full Cash Flow StatementMargins
| Gross Margin | 21.06% |
| Operating Margin | -598.75% |
| Pretax Margin | -584.80% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InspireMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.97% |
| Shareholder Yield | -43.97% |
| Earnings Yield | -43.69% |
| FCF Yield | -32.99% |
Analyst Forecast
The average price target for InspireMD is $4.50, which is 98.24% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.50 |
| Price Target Difference | 98.24% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 27, 2021. It was a reverse split with a ratio of 1:15.
| Last Split Date | Apr 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
InspireMD has an Altman Z-Score of -11.72 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.72 |
| Piotroski F-Score | 2 |
